Company: TBPH
Filing Date: 2025-04-10
Form Type: DEF 14A
Source: 0001104659-25-033819
Chunk: 72

Company: Theravance Biopharma, Inc.
Filing Date: 2025-04-10
Form: DEF 14A
Chunk 72
---
 of Irenic Capital GP and Irenic Evergreen GP. Irenic Capital and Messrs. Katz and Dodge may be deemed to beneficially own 2,680,948 shares held by Irenic Evergreen Master Fund. (7) Includes: (i) 407,708 shares subject to options exercisable within 60 days of March 21, 2025 and (ii) 30,313 RSUs and/or PSUs subject to release within 60 days of March 21, 2025. (8) Includes 18,438 RSUs and/or PSUs subject to release within 60 days of March 21, 2025. (9) Includes 19,220 RSUs and/or PSUs subject to release within 60 days of March 21, 2025. (10) Includes: (i) 97,620 shares subject to options exercisable within 60 days of March 21, 2025 and (ii) 10,537 RSUs subject to release within 60 days of March 21, 2025. (11) Includes: (i) 43,310 shares subject to options exercisable within 60 days of March 21, 2025 and (ii) 10,537 RSUs subject to release within 60 days of March 21, 2025. (12) Includes: (i) 78,286 shares subject to options exercisable within 60 days of March 21, 2025 and (ii) 10,537 RSUs subject to release within 60 days of March 21, 2025. (13) Includes: (i) 97,620 shares subject to options exercisable within 60 days of March 21, 2025 and (ii) 10,537 RSUs subject to release within 60 days of March 21, 2025. (14) Includes: (i) 109,620 shares subject to options exercisable within 60 days of March 21, 2025 and (ii) 10,537 RSUs subject to release within 60 days of March 21, 2025. (15) Includes: (i) 96,620 shares subject to options exercisable within 60 days of March 21, 2025 and (ii) 10,537 RSUs subject to release within 60 days of March 21, 2025. (16) Includes: (i